<DOC>
	<DOCNO>NCT01173718</DOCNO>
	<brief_summary>This study prospective , non-randomized , multi-center evaluation performance GORE速 ACUSEAL Vascular Graft . The study enroll patient End-Stage Renal Disease ( ESRD ) , either currently receive expect require hemodialysis prosthetic vascular graft within 30 day . Gore propose demonstrate 6 month cumulative patency GORE速 ACUSEAL Vascular Graft similar arteriovenous graft ( AVGs ) . &gt; &gt; &gt; &gt; &gt; &gt; A total 138 Subjects enrol . Once study procedure successfully complete , cannulation may occur time Investigator 's discretion . &gt; &gt; &gt; &gt; &gt; &gt; Subjects select 20 Investigational Sites .</brief_summary>
	<brief_title>Evaluation GORE速 ACUSEAL Vascular Graft Hemodialysis Access</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>&gt; 1 . Patient require creation vascular access graft hemodialysis secondary diagnosis EndStage Renal Disease . &gt; &gt; &gt; 2 . Patient currently hemodialysis ready begin hemodialysis within 30 day follow placement study device . &gt; &gt; &gt; 3 . The patient must able vascular access graft place upper extremity . &gt; &gt; &gt; 4 . The patient 18 year age old . &gt; &gt; &gt; 5 . The patient reasonable expectation remain hemodialysis 12 month . &gt; &gt; &gt; 6 . The patient his/her legal guardian understands study willing able comply followup requirement . &gt; &gt; &gt; 7 . The patient his/her legal guardian willing provide inform consent . &gt; &gt; &gt; &gt; &gt; &gt; &gt; &gt; &gt; 1 . The patient document unsuccessfully treated ipsilateral central venous stenosis via image technique . &gt; &gt; &gt; 2 . The patient currently know suspect systemic infection . &gt; &gt; &gt; 3 . The patient know hypercoagulable bleed disorder require treatment warfarin heparin . &gt; &gt; &gt; 4 . The patient previous instance Heparin Induced Thrombocytopenia type 2 ( HIT2 ) know sensitivity heparin . &gt; &gt; &gt; 5 . The patient consider live ( live donor either relate unrelated patient ) donor kidney transplant . &gt; &gt; &gt; 6 . The patient enrol another investigational study . &gt; &gt; &gt; 7 . The patient comorbid condition may limit ability comply study followup requirement . &gt; &gt; &gt; 8 . Study device intend use temporarily . &gt; &gt; &gt; 9 . The patient &gt; 2 previous arteriovenous access treatment arm . &gt; &gt; &gt; 10 . Patient take Aggrenox速 . &gt; &gt; &gt; 11 . The patient need , schedule different vascular surgical procedure within 30 day study procedure . &gt; &gt; &gt; 12 . The patient currently take maintenance immunosuppressant medication rapamycin , mycophenolate mycophenolic acid , prednisone ( &gt; 10 mg ) , cyclosporine , tacrolimus cyclophosphamide . &gt; &gt; &gt; 13 . The patient know hypercoagulable bleed disorder require treatment warfarin heparin . &gt; &gt; &gt; 14 . Life expectancy le 12 month . &gt; &gt; &gt; 15 . The patient pregnant . &gt; &gt; &gt; 16 . The patient poor compliance risk ( i.e . history IV oral drug abuse ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Hemodialysis</keyword>
	<keyword>Vascular Graft</keyword>
</DOC>